Anupam Rasayan signs LOI worth $265 Million with one of the Leading Japanese Speciality Chemical Company

Anupam Rasayan (NSE, BSE: ANURAS), one of India's leading custom synthesis & speciality chemical players, has signed Letter of Intent worth revenue of $265 Mn (₹2,186 crores) for next 5 years with one of the leading Japanese Speciality Chemical company to supply new age patented life science active ingredient. The product will be in validation phase for the next eighteen months and upon the successful validation, the supply will commence from CY2025. This product will be manufactured in our existing multipurpose manufacturing facilities.

Speaking about the contract, Anand Desai, Managing Director of Anupam Rasayan, said, "We are pleased to announce that we will be the primary global supplier of this new age patented life science active ingredient to one of the leading Japanese specialty chemical companies with the support of our Japanese business development team. With the addition of this new customer, we are delighted to include another renowned Japanese multinational in our customer portfolio. As we are fully backward integrated for this molecule, we can provide supply chain assurance to the customer without dependencies on supplies from other geographies."

The signing of this LOI represents a significant milestone for us, further cementing our position as a trusted provider of high-end customized molecules. We are excited about the opportunities this partnership brings."

Shares of Anupam Rasayan India Limited was last trading in BSE at Rs. 1086.05 as compared to the previous close of Rs. 1078.95. The total number of shares traded during the day was 5368 in over 604 trades.

The stock hit an intraday high of Rs. 1098.20 and intraday low of 1068.05. The net turnover during the day was Rs. 5789537.00.

Source : Equity Bulls

Keywords

AnupamRasayanIndia INE930P01018 LOI OrderWin Japan SpecialityChemicalCompany LifeScienceAPI